Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial

Gengiah, T. N., Heck, C. J., Lewis, L., Mansoor, L. E., Harkoo, I., Myeni, N., Baum, M. M., Moss, J. A., Rooney, J. F., Hankins, C., Pozzetto, B., Abdool Karim, S. S., & Abdool Karim, Q. (2025). Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial. Journal of the International AIDS Society, 28(2). Portico. https://doi.org/10.1002/jia2.26426
Authors:
Tanuja N Gengiah
Craig J Heck
Lara Lewis
Leila E Mansoor
Ishana Harkoo
Nqobile Myeni
Marc M Baum
John A Moss
James F Rooney
Catherine Hankins
Bruno Pozzetto
Salim S Abdool Karim
Quarraisha Abdool Karim
Affiliated Authors:
Craig J Heck
Salim S Abdool Karim
Quarraisha Abdool Karim
Columbia Affiliation:
Subjects:
Prevention and Treatment of HIV/AIDS Infection (OpenAlex Topic)
Global Epidemiology of HIV and Drug Use (OpenAlex Topic)
Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (OpenAlex Topic)
HIV Infections (MeSH)
Tenofovir (MeSH)
Anti-HIV Agents (MeSH)
Drug Implants (MeSH)
Pre-Exposure Prophylaxis (MeSH)
Alanine (MeSH)
Author Keywords:
acceptability
clinical trial
hiv prevention
implant
prep
tenofovir alafenamide
elink
Publication Type:
Article
Unique ID:
10.1002/jia2.26426
PMID:
39981604
DOI:
10.1002/jia2.26426
Journal:
Journal of the International AIDS Society
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record
View Web of Science Record

Record Created: